Topics

Articles

The era of big pharma as product-first companies must end, as services become the larger priority.

Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business Models

. He can be reached at nsaraceno@mjhlifesciences.com.

As technology continues to advance, investigators explore the legal protocol for how to handle AI-responsible injuries.

Examining the Liability Risk Surrounding Artificial Intelligence Tools in the Healthcare Environment 

Offerings include treatment plans for a considerable number of illnesses and conditions, company says. 

Optum Perks Follows Recent Trend of Expanded Telehealth Options

Study describes how a game theoretic model can successfully analyze how adoption of blockchain technology can reveal quality information. 

Using Blockchain to Minimize Consumers’ Risk Aversion Toward Generic Drugs

A discussion of where cell and gene therapies are currently doing, what's on the horizon, personalization, and much more. 

Cell and Gene Therapy Outlook: Q&A with Fran Gregory, VP of Emerging Therapies, Cardinal Health

The predicted value is largely driven by manufacturers' prioritization of brand protection. 

Report: Track-and-Trace Solutions Market Anticipated to Hit $9.8 Billion by 2028 

Bloomlife’s MFM-Pro enables healthcare providers to measure maternal and fetal heart rate in the patient's home or clinic.

FDA Approves New Device to Track Fetal, Maternal Health

EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information. 

 P360 Builds Out New Artificial Intelligence-Powered Platform

Researchers from the University of Cambridge collaborated with Pfizer to develop a platform combining automated experiments with artificial intelligence to predict chemical reactions.

New Machine Learning Model May Accelerate Drug Development

Cureus report discuss the value of AI, but the medical community must remain aware of privacy pitfalls. 

Data & Technology